Jeffrey S. Flier Sells 11,136 Shares of Scholar Rock Holding Corporation (NASDAQ:SRRK) Stock

Scholar Rock Holding Corporation (NASDAQ:SRRK - Get Free Report) Director Jeffrey S. Flier sold 11,136 shares of the stock in a transaction dated Monday, June 23rd. The stock was sold at an average price of $33.21, for a total transaction of $369,826.56. Following the transaction, the director now owns 11,136 shares in the company, valued at approximately $369,826.56. The trade was a 50.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Scholar Rock Stock Performance

Scholar Rock stock traded up $0.33 during mid-day trading on Friday, reaching $35.81. 1,735,708 shares of the company traded hands, compared to its average volume of 1,302,043. The company has a debt-to-equity ratio of 0.16, a current ratio of 10.25 and a quick ratio of 10.25. Scholar Rock Holding Corporation has a fifty-two week low of $6.76 and a fifty-two week high of $46.98. The company has a market capitalization of $3.40 billion, a price-to-earnings ratio of -14.15 and a beta of 0.28. The firm's fifty day moving average is $32.11 and its two-hundred day moving average is $35.75.

Scholar Rock (NASDAQ:SRRK - Get Free Report) last issued its quarterly earnings results on Wednesday, May 14th. The company reported ($0.67) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.63) by ($0.04). During the same quarter last year, the business posted ($0.59) EPS. On average, equities research analysts expect that Scholar Rock Holding Corporation will post -2.42 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of SRRK. Global Retirement Partners LLC raised its holdings in shares of Scholar Rock by 584.7% during the fourth quarter. Global Retirement Partners LLC now owns 897 shares of the company's stock worth $39,000 after purchasing an additional 766 shares during the last quarter. CWM LLC raised its holdings in shares of Scholar Rock by 152.8% during the first quarter. CWM LLC now owns 996 shares of the company's stock worth $32,000 after purchasing an additional 602 shares during the last quarter. GF Fund Management CO. LTD. purchased a new position in shares of Scholar Rock during the fourth quarter worth $85,000. Federated Hermes Inc. purchased a new position in shares of Scholar Rock during the first quarter worth $71,000. Finally, Strs Ohio purchased a new position in shares of Scholar Rock during the first quarter worth $77,000. Institutional investors and hedge funds own 91.08% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently commented on SRRK shares. Lifesci Capital upgraded shares of Scholar Rock to a "strong-buy" rating in a research note on Tuesday, June 3rd. Wedbush reiterated an "outperform" rating and set a $50.00 price objective on shares of Scholar Rock in a research note on Wednesday, June 18th. Six analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $42.67.

About Scholar Rock

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.